These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 7704956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mechanism of dissociation of cortisol and adrenal androgen secretion after removal of adrenocortical adenoma in patients with Cushing's syndrome.
    Nawata H, Higuchi K, Yanase T, Takayanagi R, Kato K, Ibayashi H.
    Endocrinol Jpn; 1985 Oct; 32(5):691-700. PubMed ID: 2936600
    [Abstract] [Full Text] [Related]

  • 3. Subclinical Cushing's syndrome in adrenal incidentaloma.
    Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A.
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
    [Abstract] [Full Text] [Related]

  • 4. 131I-6 beta-iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas.
    Bardet S, Rohmer V, Murat A, Guillemot C, Maréchaud R, Chupin M, Lecomte P, Simon D, Delemer B, Schneebelli S, Beutter D, Jacquin V, Peltier P, Charbonnel B.
    Clin Endocrinol (Oxf); 1996 May; 44(5):587-96. PubMed ID: 8762736
    [Abstract] [Full Text] [Related]

  • 5. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
    Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos N.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
    [Abstract] [Full Text] [Related]

  • 6. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H, Terano T, Yamamoto K, Tomizuka T, Oeda T, Saito Y, Tamura Y, Sasano H.
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [Abstract] [Full Text] [Related]

  • 7. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
    Tsagarakis S, Tsigos C, Vassiliou V, Tsiotra P, Pratsinis H, Kletsas D, Trivizas P, Nikou A, Mavromatis T, Sotsiou F, Raptis S, Thalassinos N.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
    [Abstract] [Full Text] [Related]

  • 8. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F, Masini AM, Opocher G, Giovagnetti M, Arnaldi G.
    Horm Res; 1997 Feb; 47(4-6):284-9. PubMed ID: 9167966
    [Abstract] [Full Text] [Related]

  • 9. Endocrine activity of the "silent" adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone.
    Hensen J, Buhl M, Bähr V, Oelkers W.
    Klin Wochenschr; 1990 Jun 19; 68(12):608-14. PubMed ID: 2165544
    [Abstract] [Full Text] [Related]

  • 10. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G.
    J Clin Endocrinol Metab; 2000 Apr 19; 85(4):1440-8. PubMed ID: 10770179
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
    Grossrubatscher E, Vignati F, Possa M, Lohi P.
    J Endocrinol Invest; 2001 Dec 19; 24(11):846-55. PubMed ID: 11817708
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients.
    Kasperlik-Zeluska AA, Rosłonowska E, Słowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H.
    Clin Endocrinol (Oxf); 1997 Jan 19; 46(1):29-37. PubMed ID: 9059555
    [Abstract] [Full Text] [Related]

  • 16. [Pre-toxic adrenocortical adenoma ("pre-Cushing syndrome"): role of 17-hydroxyprogesterone dosage under ACTH analog stimulation. Apropos of a case].
    Vlaeminck V, Dewailly D.
    Ann Endocrinol (Paris); 1997 Jan 19; 58(5):413-7; discussion 417-20. PubMed ID: 9686000
    [Abstract] [Full Text] [Related]

  • 17. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
    Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T, Sasano H.
    Endocr J; 2001 Apr 19; 48(2):167-74. PubMed ID: 11456263
    [Abstract] [Full Text] [Related]

  • 18. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC, Mitty HA, Gabrilove JL.
    J Urol; 1988 Jul 19; 140(1):11-5. PubMed ID: 2967899
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
    Klose M, Jørgensen K, Kristensen LØ.
    Clin Endocrinol (Oxf); 2004 Sep 19; 61(3):394-9. PubMed ID: 15355458
    [Abstract] [Full Text] [Related]

  • 20. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Verhelst JA, Trainer PJ, Howlett TA, Perry L, Rees LH, Grossman AB, Wass JA, Besser GM.
    Clin Endocrinol (Oxf); 1991 Aug 19; 35(2):169-78. PubMed ID: 1657460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.